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Sustained calcium signaling in T cells is critical for development and activation. In this issue of Immunity,
Matza et al. (2007) demonstrate that the huge scaffold protein, AHNAK1, interacts with L-type calcium chan-
nels, regulates Ca2+ influx, and defends against Leishmania major infection.Immunity 28, January 2008 ª2008 Elsevier Inc. 13Calcium ions (Ca2+) are essential second
messengers. Their widespread roles in
biology are paralleled within the immune
system. Engagement of several different
tyrosine kinase and nontyrosine kinase
receptors stimulate Ca2+ influx in many
immune cells including macrophages,
T cells, B cells, natural killer cells, mast
cells, and dendritic cells. In T cells, anti-
gen engagement of the T cell receptor
(TCR) initiates an influx of Ca2+. This
activates calcineurin to dephosphorylate
NFATc transcription factors. Subsequent
nuclear localization and formation of
NFATc complexes turn on and off genes
required for T cell development, activa-
tion, cytokine production, and anergy
(Wu et al., 2007).
The primary channel machinery used
to maintain increased intracellular Ca2+
concentrations in T cells is the calcium
release-activated channel (CRAC). TCR
triggering increases intracellular inositol
1,4,5 phosphate (InsP3), opening InsP3 re-
ceptors in the endoplasmic reticulum (ER).
This transient Ca2+ release opens CRAC
channels in the plasmamembrane and re-
sults in a sustainedCa2+ rise. Recent stud-
ies identified STIM1 as the mammalian
ER Ca2+ sensor and Orai1 (also known as
CRACM1)asanelementof themammalian
CRAC channel. In resting T cells, both
Orai1 and STIM1 are distributed primarily
throughout the plasma membrane and
ER, respectively. Upon store depletion,
Orai1 andSTIM1 redistribute tositeswhere
the ER and plasmamembrane are in close
proximity and STIM1 activates Orai1 by
a yet unknown mechanism (Feske et al.,
2006; Liou et al., 2005; Vig et al., 2006).
In addition to the CRAC channel, T cells
express among others the L-type voltage-gated Ca2+ (Cav1) channels. These chan-
nels are composed of transmembrane a1,
d, and g subunits and the extracellular a2
and intracellular b subunits. Within Cav1,
one of four possible a1 subunits (Cav1.1
to Cav1.4) can associate with one of four
possible b subunits (b1 to b4). The b sub-
unit is required for proper membrane
insertion of the a1 subunit. After insertion,
b becomes an allosteric modulator of
Cav1. Typically connected with activation
in excitable cells such as neurons and
cardiomyocytes, these voltage-gated
channels are surprisingly expressed in
T cells (Badou et al., 2006).
Analysis of b3 null and b4 mutant mice
(Badou et al., 2006) show that both the
initial and sustained rise in Ca2+ are atten-
uated after TCR triggering, implicating
Cav1 in the regulation of intracellular
Ca2+ concentrations after T cell activa-
tion. Why are these voltage-gated chan-
nels expressed in nonexcitable T cells?
The authors find that KCl-induced depo-
larization does not open Cav1. Therefore,
during T cell activation, Cav1 appear to
open by a mechanism different than that
in excitable cells. In this issue of Immunity,
Matza et al. (2007) propose that the giant
scaffold protein AHNAK1 controls plasma
membrane localization of Cav1 channels.
AHNAK1 was originally identified as a
tumor-related protein involved in prolifer-
ation. It is located primarily in the nucleus,
but is also found in the cytoplasm and at
the plasma membrane (Haase, 2007).
Matza et al. (2007) examined the
role of AHNAK1 in T cells by analy-
zing Ahnak1/ mice. In wild-type mice,
AHNAK1 is expressed strongly in CD4+
T cells and weakly in thymocytes. Thymo-
cyte development, splenic lymphoid com-position, and memory T cell distribution
appeared to be normal in the Ahnak1/
mice. After activation, null CD4+ T cells
show substantially reduced proliferation
and IL-2 production. The proliferation
defect is in part caused by the failure to
make IL-2 because addition of IL-2 to
T cells partially overcame this defect.
To investigate the defective IL-2 pro-
duction by Ahnak1/ mice, the authors
examined NFAT localization in null T cells
after stimulation and found a marked
reduction in NFATc1 and c2 nuclear local-
ization because of attenuated Ca2+ sig-
naling. Both the initial rise and plateau of
intracellular Ca2+ were reduced. This sug-
gested that the Ca2+ signaling defect
caused the proliferation defect. Indeed,
Matza et al. (2007) were able to rescue
proliferation in mice with ionomycin,
which artificially drains intracellular stores
and stimulates Ca2+ influx by a mecha-
nism that resembles the physiologic
mechanism of Ca2+ entry.
Previously, AHNAK1 had been reported
to interact with the Cav1 b subunit in other
cells types (Hohaus et al., 2002). Along
these lines, Matza et al. (2007) found
what appears to be a robust interaction
between endogenous AHNAK1 and en-
dogenous Cav1 b2 (but not b3) in T cells.
Direct interaction with b1 and b4 was not
tested because of a lack of available anti-
bodies. AHNAK1 may interact with b4
because this same group has previously
shown that b3 null;b4 mutant mice dis-
played a similar attenuated Ca2+ pheno-
type (Badou et al., 2006).
The potential effect of this interaction
was investigated by analyzing expression
and cellular distribution of Cav1 in
Ahnak1/ mice. Protein expression of
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PreviewsFigure 1. AHNAK1 LocalizesMembrane Expression of L-type Cav1 CalciumChannels during
T cell activation
During T cell activation, Ca2+ release from intracellular stores in the ER open CRAC channels, leading to
sustained Ca2+ influx into the T cell, activation of calcineurin, and nuclear import of NFATc proteins, which
regulate immune-response genes. In the absence of the scaffold protein AHNAK1, membrane localization
of Cav1 is reduced, leading to reducedCa
2+ influx.Matza et al. (2007) propose that AHNAK1 helps regulate
membrane localization of Cav1 channels during T cell activation potentially through the Cav1 b subunit.Cav1.1 a1 and Cav1.2 a1 increased after
stimulation in wild-type, but not null,
T cells. Surprisingly, mRNA expression
was upregulated similarly in null and
wild-type T cells. Therefore, AHNAK1
must influence post-translational pro-
cessing of a1 subunits. Consistent with
this, activated null T cells had 50% less
Cav1.1 a1 protein at their plasma mem-
brane than wild-type T cells, but similar
amounts of intracellular protein. Hence,
the authors propose that AHNAK1 is
required for intact membrane expression
of Cav1 complexes (Figure 1). Although
supported by the observation that naive
Ahnak1/ T cells have 80% less Cav1.1
a1 protein at their plasma membrane,
a role for AHNAK1 in other post-transla-
tional processing events is also possible.
The expression of Cav1 a1 subunits was
analyzed only after stimulation at 0 and
48 hr. A time course would yield much
more information; especially because
the attenuated Ca2+ signaling profile
occurs on a shorter time scale, minutes
to hours after activation.
To understand the role of AHNAK1 in
immune responses in vivo, the authors
examined the response of the Ahnak1/
mice to the Leishmania major para-
site. Mice that mount a T helper 1 (Th1)14 Immunity 28, January 2008 ª2008 Elsevieresponse to L. major usually heal,
whereas mice that mount a Th2 response
usually die (Locksley et al., 1987). The au-
thors found that intradermal foot infection
was not cleared well by null mice. As ex-
pected, IFN-g production was severely
reduced in the Ahnak1/ mice. Unex-
pectedly, the null mice produced sub-
stantially higher amounts of IL-4. This is
surprising because in vitro T cell activa-
tion in null mice was defective. It is gener-
ally thought that calcineurin-NFAT signal-
ing is upstream of the decision to make
both Th1 and Th2 cells because the
activation of genes such as T-bet and
production of both cell types is blocked
by cyclosporine A (Wu et al., 2007).
Thus,Ahnak1/mice would be expected
to respond poorly to all activation signals.
Instead, it appears that AHNAK1 may
have a role in T helper differentiation. It
would be interesting to analyze prolifera-
tion of CD4+ T cells after infection. Addi-
tional analysis of other in vivo activation
and infection models would yield insight
into the physiological role of AHNAK1.
More broadly, it is surprising that devel-
opment in Ahnak1/ mice is normal,
because calcineurin-NFAT signaling is
essential for the activation of Erk kinase
and subsequent positive selection in ther Inc.thymus as well as the development of
many other mammalian organs and cell
types (Gallo et al., 2007; Wu et al., 2007).
Perhaps this is because the product of
a second AHNAK-like gene is expressed
in these cell types. If AHNAK is really
a component of a broadly acting develop-
mental pathway upstream of calcineurin-
NFAT, onewould expect double knockout
mice to have multiple development de-
fects in organogenesis as well as a com-
plete block in T cell development similar
to the calcineurin and NFATc null mice.
This study also raises important mech-
anistic questions: what component of
total Ca2+ influx is dependent on this path-
way? How does AHNAK1 regulate Cav1
channels? Because AHNAK1 is found in
the nucleus and cytoplasm in addition to
near the membrane, it could be responsi-
ble for the proper processing of Cav1
rather than directly involved in Ca2+ con-
ductance. Does this Ca2+ influx pathway
synergize with better characterized
mechanisms? The production of mutant
mice and the characterization of their
defects should provide the essential
reagents to answer these questions.
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